Mkts

LENZ Therapeutics, Inc.

NASDAQ: LENZ
$3.27-0.30 (-8.40%)
As of Oct 16, 4:00 PM ET

Key statistics

Day range
3.213.56
52-week range
3.2142.98
Today
Open3.56
Previous close3.27
Volume—
Valuation
Market cap102.74M
P/E ratio—
EPS (TTM)-4.08
Income & risk
Dividend / yield—
Beta2.21
Avg volume840.9K
Discussion

LENZ News

Stories mentioning LENZ from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue1,9010.00
Cost of Goods Sold1,0760.00
Gross Profit825.0018,6700.000.000.000.000.000.00
Operating Expenses
Research & Development0.000.003,7919,0615,8185,8686,4516,945
Sales General & Admin44,96039,63327,59612,79611,1139,3576,4947,407
Total Operating Expenses31,38721,85716,93115,22512,94514,352
Operating Income (Loss)(44,135)(38,463)(18,887)(16,857)(16,931)(15,225)(12,945)(14,352)
Interest Income2,6442,9862,2012,2462,3232,5662,7362,463
Interest Expense
Other Expense3.00(417.00)(14.00)199.00(11.00)8.00(6.00)1,635
Pretax Income(16,700)(14,412)(10,215)(10,254)
Tax Provision0.00500.000.000.00
Net Income (Loss)(41,488)(35,896)(16,700)(14,912)(14,619)(12,652)(10,215)(10,254)
Earnings Per Share (Basic)(1.32)(1.25)(0.59)(0.53)(0.53)(0.59)(0.38)(0.40)
Earnings Per Share (Diluted)(1.32)(1.25)(0.59)(0.53)(0.53)(0.59)(0.38)(0.40)
Weighted Average Shares Outstanding (Basic)31,35328,81328,54128,07927,52621,28127,17225,609
Weighted Average Shares Outstanding (Diluted)31,35328,81328,54128,07927,52621,28127,17225,609

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About LENZ

LENZ Therapeutics, Inc. (NASDAQ: LENZ) is a stock listed on the Nasdaq Stock Market under the ticker symbol LENZ. It last traded at $3.27 (Oct 16, 2026, 4:00 PM ET), down 8.4% on the day. That gives LENZ Therapeutics a market capitalisation of $102.7M.

Over the past 52 weeks LENZ has traded between $3.21 and $42.98.

Revenue for the quarter ended Mar 31, 2026 was $1.9M; a net loss of $41.5M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$1.9M-$41.5M-2182.4%
Dec 31, 2025—-$35.9M—
Sep 30, 2025—-$16.7M—
Jun 30, 2025—-$14.9M—

From LENZ Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…